Showing results (651-660 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|August 30, 2014
Experience with trabectedin in an advanced sarcoma patient on peritoneal dialysis for end-stage renal failureMaung Maung Myat Moe, Carlos Fernandez Teruel, Arturo Soto-MatosChemotherapy|June 21, 2016
Mutant p53 Gain of Function and Chemoresistance: The Role of Mutant p53 in Response to Clinical ChemotherapyChao He, Lun Li, Xuan Guan, et al.Chemotherapy|March 8, 2016
Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosisA R Barbosa, K R Caleffi-Ferracioli, C Q F Leite, et al.Chemotherapy|June 8, 2021
Durable Molecular Remission in an Elderly Patient Affected by Relapsed Ph'+ Acute Lymphoblastic Leukemia with T315I and Concomitant p190 and p210 Expression Achieved by Inotuzumab and PonatinibMatteo Molica, Carla Mazzone, Iole Cordone, et al.Chemotherapy|January 1, 1985
Measurement of adenine uptake as an in vitro screen for antitrichomonal agentsJ G Meingassner, P G Heyworth, L HavelecChemotherapy|July 26, 2022
Treatment Tolerance of Cetuximab versus Alternative Chemotherapy Agents in Non-Cisplatin Candidates with Head and Neck Cancer Receiving Concurrent ChemoradiotherapyRyan T Morse, Rohit G Ganju, Rishi Neeranjun, et al.Chemotherapy|January 1, 1985
Latamoxef in combination with aminoglycosides against Pseudomonas aeruginosa: similarity with ticarcillinS D Sears, B A Tatem, H C StandifordChemotherapy|January 1, 1986
The development of chromosomally coded beta-lactamase production by Escherichia coli after in vitro selection with ampicillin, cefoxitin and ceftriaxoneR Egger, G LebekChemotherapy|January 1, 1989
Potencies of ceftriaxone and cefotaxime in a single chamber pharmacokinetic system simulating their in vivo half-livesJ Unowsky, J Sattler, I H PatelPageof 308